Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972362-25-000226
Filing Date
2025-03-04
Accepted
2025-03-04 17:10:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3901
  Complete submission text file 0001972362-25-000226.txt   5402
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-33093 | Film No.: 25706217
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LIGAND PHARMACEUTICALS INC 3911 SORRENTO VALLEY BOULEVARD, STE 110 SAN DIEGO CA 92121
Business Address
Espinoza Octavio (Reporting) CIK: 0001905248 (see all company filings)

Type: 144